PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,056,071 | +1558.3% | 666,227 | +627.3% | 0.01% | – |
| Q4 2022 | $968,212 | +135.0% | 91,600 | 0.0% | 0.00% | – |
| Q3 2022 | $412,000 | +18.4% | 91,600 | +5.4% | 0.00% | – |
| Q2 2022 | $348,000 | -45.3% | 86,900 | 0.0% | 0.00% | – |
| Q1 2022 | $636,000 | +30.6% | 86,900 | +0.3% | 0.00% | – |
| Q4 2021 | $487,000 | -12.1% | 86,600 | 0.0% | 0.00% | – |
| Q3 2021 | $554,000 | -24.1% | 86,600 | 0.0% | 0.00% | – |
| Q2 2021 | $730,000 | +61.1% | 86,600 | +100.5% | 0.00% | – |
| Q1 2021 | $453,000 | -49.0% | 43,200 | -17.7% | 0.00% | – |
| Q4 2020 | $889,000 | +31.9% | 52,500 | 0.0% | 0.00% | – |
| Q3 2020 | $674,000 | -12.2% | 52,500 | -3.5% | 0.00% | – |
| Q2 2020 | $768,000 | – | 54,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |